Related Experiment Video
Updated: Aug 16, 2026

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
Emerging fungal diseases
1University Hospital, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Abstract:
The epidemiology of invasive fungal infection is evolving. Yeasts other than Candida albicans and molds other than Aspergillus fumigatus have emerged as significant causes of invasive mycoses in severely immunocompromised patients. Although, in some instances, these changes may be related to medical interventions, such as the use of antifungal agents in prophylaxis, in the majority of cases, they seem to be a consequence of changes in the host, such as more-severe immunosuppression or different types of immunosuppression impacting both risk periods and the infections that occur. These factors have altered the epidemiology of infection in organ transplant recipients, premature newborns, and critically ill patients. This review discusses the epidemiology of some fungal infections that have emerged in the past few years, with an emphasis on the potential factors associated with their emergence and on practical implications of these epidemiological changes.
Insights
Invasive fungal infections are changing, with non-Candida yeasts and non-Aspergillus molds becoming more common in immunocompromised patients due to host factors and medical interventions.
Area of Science:
- Medical Mycology
- Infectious Diseases Epidemiology
- Immunocompromised Host Infections
Background:
- The landscape of invasive fungal infections (IFIs) is shifting.
- Non-albicans Candida yeasts and non-fumigatus Aspergillus molds are increasingly implicated in IFIs.
- Severely immunocompromised patients are at heightened risk.
Purpose of the Study:
- To review the evolving epidemiology of emerging fungal infections.
- To identify factors contributing to the rise of these infections.
- To discuss the clinical and practical implications of these epidemiological changes.
Main Methods:
- Literature review of recent epidemiological data on IFIs.
- Analysis of factors influencing the emergence of fungal pathogens.
- Discussion of impact on specific patient populations.
Main Results:
- Emergence of yeasts beyond Candida albicans and molds beyond Aspergillus fumigatus as significant pathogens.
- Changes in host factors, including increased severity and types of immunosuppression, are key drivers.
- Epidemiological shifts observed in organ transplant recipients, neonates, and critically ill patients.
Conclusions:
- The epidemiology of IFIs is dynamic, driven by host and iatrogenic factors.
- Understanding these shifts is crucial for managing infections in vulnerable populations.
- Proactive strategies are needed to address the changing spectrum of IFIs.
Related Concept Videos
Fungal Phylum Microsporidia
Fungal Group Zygomycota
Fungal Phylum Ascomycota
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Fungal Phylum Basidiomycota
Cryptococcal Meningitis

